{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T12:16:24Z","timestamp":1771935384607,"version":"3.50.1"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.vaccine.2012.02.040","type":"journal-article","created":{"date-parts":[[2012,8,31]],"date-time":"2012-08-31T02:04:19Z","timestamp":1346378659000},"page":"C61-C65","source":"Crossref","is-referenced-by-count":18,"special_numbering":"S3","title":["Immunising the HIV-infected child: A view from sub-Saharan Africa"],"prefix":"10.1016","volume":"30","author":[{"given":"M. Jeffrey","family":"Mphahlele","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siyazi","family":"Mda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8643","key":"10.1016\/j.vaccine.2012.02.040_bib0005","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0140-6736(89)92876-6","article-title":"Horizontal transmission of hepatitis B virus","volume":"1","author":"Davis","year":"1989","journal-title":"Lancet"},{"issue":"9323","key":"10.1016\/j.vaccine.2012.02.040_bib0010","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1016\/S0140-6736(02)08909-2","article-title":"HIV-1\/AIDS and maternal and child health in Africa","volume":"359","author":"Dabis","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2012.02.040_bib0015","unstructured":"UNAIDS Report on the Global AIDS Epidemic 2010. <http:\/\/www.unaids.org\/en\/media\/unaids\/contentassets\/documents\/unaidspublication\/2010\/20101123_globalreport_en.pdf> [accessed 10.08.11]."},{"issue":"1","key":"10.1016\/j.vaccine.2012.02.040_bib0020","first-page":"61","article-title":"Immunisation of children at risk of infection with human immunodeficiency virus","volume":"81","author":"Moss","year":"2003","journal-title":"Bull World Health Organ"},{"issue":"2","key":"10.1016\/j.vaccine.2012.02.040_bib0025","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1055\/s-2003-39951","article-title":"Hepatitis B in human immunodeficiency virus infected patients: epidemiology, natural history, and treatment","volume":"23","author":"Thio","year":"2003","journal-title":"Semin Liver Dis"},{"issue":"September (RR-11)","key":"10.1016\/j.vaccine.2012.02.040_bib0030","first-page":"1","volume":"58","author":"Centres for Disease Control and Prevention","year":"2009","journal-title":"MMWR Recomm Rep"},{"issue":"Suppl. 3","key":"10.1016\/j.vaccine.2012.02.040_bib0280","doi-asserted-by":"crossref","first-page":"C45","DOI":"10.1016\/j.vaccine.2012.02.021","article-title":"An update after 16 years of hepatitis B vaccination in South Africa","volume":"30","author":"Burnett","year":"2012","journal-title":"Vaccine"},{"issue":"Suppl. 3","key":"10.1016\/j.vaccine.2012.02.040_bib0285","doi-asserted-by":"crossref","first-page":"C28","DOI":"10.1016\/j.vaccine.2012.03.032","article-title":"Introducing human papillomavirus vaccines into clinical practice in South Africa","volume":"30","author":"Botha","year":"2012","journal-title":"Vaccine"},{"issue":"Suppl. 3","key":"10.1016\/j.vaccine.2012.02.040_bib0290","first-page":"C21","article-title":"Introduction of pneumococcal conjugate vaccine into the public immunization program in South Africa: testimony to success in translating research into policy","volume":"30","author":"Mahdi","year":"2012","journal-title":"Vaccine"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2012.02.040_bib0050","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.vaccine.2008.10.004","article-title":"Reduced detection and levels of protective antibodies to hepatitis B vaccine in under 2-year-old HIV positive South African children at a paediatric outpatient clinic","volume":"27","author":"Simani","year":"2009","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2012.02.040_bib0055","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s11904-009-0014-z","article-title":"Optimal timing of routine vaccination in HIV-infected persons","volume":"6","author":"Crane","year":"2009","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2012.02.040_bib0060","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S1473-3099(10)70116-X","article-title":"Do children infected with HIV receiving HAART need to be revaccinated?","volume":"10","author":"Sutcliffe","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2012.02.040_bib0065","unstructured":"World Health Organisation. Weekly Epidemiological Record, 2007; 82 (21): 186\u201396. http:\/\/www.who.int\/wer."},{"key":"10.1016\/j.vaccine.2012.02.040_bib0070","unstructured":"World Health Organisation. Weekly Epidemiological Record, 2011; 86 (5): 37\u201344. http:\/\/www.who.int\/wer."},{"issue":"November (Suppl. 1)","key":"10.1016\/j.vaccine.2012.02.040_bib0075","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1086\/605027","article-title":"A review of rotavirus infection in and vaccination of human immunodeficiency virus-infected children","volume":"200","author":"Steele","year":"2009","journal-title":"J Infect Dis"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2012.02.040_bib0080","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/INF.0b013e3181f42db9","article-title":"Safety, reactogenicity, and immunogenicity of human rotavirus vaccine RIX4414 in human immunodeficiency virus-positive infants in South Africa","volume":"30","author":"Steele","year":"2011","journal-title":"Pediatr Infect Dis J"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2012.02.040_bib0085","first-page":"1376","article-title":"Consensus statement on the revised World Health Organization recommendations for BCG vaccination in HIV-infected infants","volume":"12","author":"Hesseling","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2012.02.040_bib0090","first-page":"1331","article-title":"Bacille Calmette-Gu\u00e9rin vaccine-related disease in HIV-infected children: a systematic review","volume":"13","author":"Azzopardi","year":"2009","journal-title":"Int J Tuberc Lung Dis"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2012.02.040_bib0095","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1128\/JCM.01539-07","article-title":"Early infant Human immunodeficiency virus type 1 detection suitable for resource-limited settings with multiple circulating subtypes by use of nested three-monoplex DNA PCR and dried blood spots","volume":"46","author":"Zhang","year":"2008","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2012.02.040_bib0100","series-title":"5th South African AIDS conference","article-title":"Results of an evaluation of effectiveness of the National PMTCT Programme at six weeks postpartum, South Africa","author":"Goga","year":"2011"},{"issue":"9024","key":"10.1016\/j.vaccine.2012.02.040_bib0105","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0140-6736(05)65044-1","article-title":"Measles case fatality by sex, vaccination status, and HIV-1 antibody in Zambian children","volume":"348","author":"Oshitani","year":"1996","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.vaccine.2012.02.040_bib0110","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1086\/526525","article-title":"HIV type 1 infection is a risk factor for mortality in hospitalized Zambian children with measles","volume":"46","author":"Moss","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2012.02.040_bib0115","first-page":"1271","article-title":"Measles in hospitalized African children with human immunodeficiency virus","volume":"142","author":"Sension","year":"1988","journal-title":"Am J Dis Child"},{"issue":"10","key":"10.1016\/j.vaccine.2012.02.040_bib0120","first-page":"1125","article-title":"Antibody response to measles and rubella vaccine by children with HIV infection","volume":"6","author":"Bre\u00f1a","year":"1993","journal-title":"J Acquir Defic Syndr"},{"issue":"1","key":"10.1016\/j.vaccine.2012.02.040_bib0125","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/ajh.2830460106","article-title":"Immune and serologic profiles of HIV-infected and noninfected hemophilic children and adolescents Hemophilia Growth and Development Study Group","volume":"46","author":"Jason","year":"1994","journal-title":"Am J Hematol"},{"issue":"3","key":"10.1016\/j.vaccine.2012.02.040_bib0130","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1086\/519169","article-title":"Immunogenicity of standard-titer measles vaccine in HIV-1-infected and uninfected Zambian children: an observational study","volume":"196","author":"Moss","year":"2007","journal-title":"J Infect Dis"},{"issue":"10","key":"10.1016\/j.vaccine.2012.02.040_bib0135","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1086\/592756","article-title":"Evaluation of the immune response to a 2-dose measles vaccination schedule administered at 6 and 9 months of age to HIV-infected and HIV-uninfected children in Malawi","volume":"198","author":"Helfand","year":"2008","journal-title":"J Infect Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2012.02.040_bib0140","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1086\/605648","article-title":"HIV-1 infection in Zambian children impairs the development and avidity of measles virus-specific immunoglobulin G after vaccination and infection","volume":"2006","author":"Nair","year":"2009","journal-title":"J Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2012.02.040_bib0145","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1097\/00006454-199211120-00004","article-title":"Population-based study of measles and measles immunization in human immunodeficiency virus-infected children","volume":"11","author":"Palumbo","year":"1992","journal-title":"Pediatr Infect Dis J"},{"issue":"5","key":"10.1016\/j.vaccine.2012.02.040_bib0150","first-page":"653","article-title":"Measles antibody in vaccinated human immunodeficiency virus type 1-infected children","volume":"97","author":"Arpadi","year":"1996","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.vaccine.2012.02.040_bib0155","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/ije\/28.2.341","article-title":"The effect of human immunodeficiency virus-1 infection and stunting on measles immunoglobulin-G levels in children vaccinated against measles in Uganda","volume":"28","author":"Waibale","year":"1999","journal-title":"Int J Epidemiol"},{"issue":"2","key":"10.1016\/j.vaccine.2012.02.040_bib0160","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1093\/infdis\/165.2.262","article-title":"Increased risk of early measles in infants of human immunodeficiency virus type 1-seropositive mothers","volume":"165","author":"Embree","year":"1992","journal-title":"J Infect Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2012.02.040_bib0165","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1086\/522989","article-title":"the influence of HIV-1 exposure on levels of passively acquired antibodies to measles virus in Zambian infants","volume":"45","author":"Scott","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2012.02.040_bib0170","unstructured":"World Health Organisation. Weekly Epidemiological Record No. 14, 2004: 130\u201342. http:\/\/www.who.int\/wer."},{"issue":"1","key":"10.1016\/j.vaccine.2012.02.040_bib0175","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1086\/520136","article-title":"Implications of the human immunodeficiency virus epidemic for control and eradication of measles","volume":"29","author":"Moss","year":"1999","journal-title":"Clin Infect Dis"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2012.02.040_bib0180","doi-asserted-by":"crossref","first-page":"S164","DOI":"10.1093\/infdis\/jir071","article-title":"Measles vaccination in HIV-infected children: systematic review and meta-analysis of safety and immunogenicity","volume":"204","author":"Scott","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2012.02.040_bib0185","unstructured":"World Health Organisation. Polio vaccines and polio immunization in the pre-eradication era: Weekly Epidemiological Record, WHO position paper. No. 23, 2010; 85: 213\u201328."},{"key":"10.1016\/j.vaccine.2012.02.040_bib0190","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0140-6736(94)90903-2","article-title":"Vaccine-associated paralytic poliomyelitis and HIV infection","volume":"343","author":"Ion-Nedelcu","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2012.02.040_bib0195","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1136\/bmj.318.7187.841","article-title":"Paralytic poliomyelitis associated with live oral poliomyelitis vaccine in child with HIV infection in Zimbabwe: case report","volume":"318","author":"Chitsike","year":"1999","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2012.02.040_bib0200","first-page":"9","article-title":"Cost analysis of post-polio certification immunisation policies","volume":"82","author":"Sangrujee","year":"2004","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2012.02.040_bib0205","first-page":"3","article-title":"Search for poliovirus carriers among people with primary immune deficiency diseases in the United States, Mexico, Brazil, and the United Kingdom","volume":"82","author":"Halsey","year":"2004","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2012.02.040_bib0210","first-page":"63","article-title":"Will the three steps for containment of poliovirus be enough to convince policy-makers?","volume":"82","author":"Schoub","year":"2004","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2012.02.040_bib0215","first-page":"65","article-title":"Poliovirus vaccine strains will continue to circulate long after wild strains have been eradicated","volume":"82","author":"Schatzmayr","year":"2004","journal-title":"Bull World Health Organ"},{"issue":"July (RR-7)","key":"10.1016\/j.vaccine.2012.02.040_bib0220","first-page":"1","article-title":"Yellow fever vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"59","author":"Staples","year":"2010","journal-title":"MMWR Recomm Rep"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2012.02.040_bib0225","doi-asserted-by":"crossref","first-page":"359","DOI":"10.4269\/ajtmh.2012.11-0525","article-title":"The safety of yellow fever vaccine 17D or 17DD in children, pregnant women, HIV+ individuals, and older persons: systematic review","volume":"86","author":"Thomas","year":"2012","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2012.02.040_bib0230","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1086\/518986","article-title":"Influenza virus infection is a primary cause of febrile respiratory illness in HIV infected adults, despite vaccination","volume":"45","author":"Klein","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2012.02.040_bib0235","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S1473-3099(09)70175-6","article-title":"Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses","volume":"9","author":"Kunisaki","year":"2009","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2012.02.040_bib0240","first-page":"223","article-title":"Influenza guideline for South Africa \u2013 update 2008","volume":"98","author":"Green","year":"2008","journal-title":"S Afr Med J"},{"issue":"RR15","key":"10.1016\/j.vaccine.2012.02.040_bib0245","article-title":"General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"55","author":"Centres for Disease Control and Prevention","year":"2006","journal-title":"Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2012.02.040_bib0250","unstructured":"World Health Organisation. http:\/\/www.who.int\/csr\/disease\/swineflu\/en\/index.html [accessed 10.08.11]."},{"issue":"6","key":"10.1016\/j.vaccine.2012.02.040_bib0255","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1093\/infdis\/174.6.1332","article-title":"The effect of influenza vaccination on human immunodeficiency virus type 1 load: a randomized, double-blind, placebo-controlled study","volume":"174","author":"Glesby","year":"1996","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2012.02.040_bib0260","first-page":"38","article-title":"Efficacy and clinical effectiveness in reducing the incidence of influenza in HIV-infected individuals: a meta-analysis","volume":"September","author":"Atashili","year":"2006","journal-title":"BMC Infect Dis"},{"issue":"August (33)","key":"10.1016\/j.vaccine.2012.02.040_bib0265","doi-asserted-by":"crossref","first-page":"4210","DOI":"10.1016\/j.vaccine.2008.05.054","article-title":"Shedding of live vaccine virus, comparative safety, and influenza-specific antibody responses after administration of live attenuated and inactivated trivalent influenza vaccines to HIV-infected children","volume":"26","author":"Levin","year":"2008","journal-title":"Vaccine"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2012.02.040_bib0275","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1136\/bmjqs.2010.047316","article-title":"Flu and pneumococcal immunisations in HIV-infected: methodological quality of current recommendations","volume":"20","author":"Giannatassio","year":"2011","journal-title":"BMJ Qual Saf"},{"issue":"April (3)","key":"10.1016\/j.vaccine.2012.02.040_bib0270","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S1386-6532(02)00047-1","article-title":"Comparison of the effects of acute influenza infection and influenza vaccination on HIV viral load and CD4 cell counts","volume":"26","author":"Skiest","year":"2003","journal-title":"J Clin Virol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12002344?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12002344?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T23:54:49Z","timestamp":1542758089000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X12002344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":55,"alternative-id":["S0264410X12002344"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2012.02.040","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}